Teladoc Health Reports Second-Quarter 2021 Results, Raises Full-Year Revenue Guidance

Go back to Teladoc Health Reports Second-Quarter 2021 Results, Raises Full-Year Revenue Guidance
(NYSE: TDOC) Delayed: 7.84 +0.15 (1.95%)
Previous Close $7.69    52 Week High $22.00 
Open $7.68    52 Week Low $9.08 
Day High $7.90    P/E N/A 
Day Low $7.67    EPS $0.00 
Volume 466,886